Shares of Evolent Health (EVH) have gained 9.4% over the past four weeks to close the last trading session at $33.75, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $45.38 indicates a potential upside of 34.5%.The mean estimate comprises 13 short-term price targets with a standard deviation of $7.37. While the lowest estimate of $34 indicates a 0.7% increase from the current pr ...